Genetic characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae collected from healthy turkeys
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.18973 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Amel Romdhani und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Tunis El Manar, Laboratory of bacteriological research, Tunisian Institute of Veterinary Research, Bab Saadoun, Tunis 1006, Tunisia. Hauptthemen laut MEDLINE: beta-Lactamases, Escherichia coli, Klebsiella pneumoniae, Turkeys. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-En) from turkeys via food chain and environmental contamination is a human health concern. Methodology: Seventy fecal samples were collected from healthy turkeys and streaked on Tryptone Bile X-Glucoronide (TBX) supplemented with 2 mg/L of cefotaxime and on TBX supplemented with 1 mg/L of imipenem. ESBL production and susceptibility to antibiotics were studied according to CLSI guidelines. Genes encoding for ESBLs (SHV, CTX-M, TEM), carbapenemases (IMI, KPC, OXA48, NDM), tetracyclines (tetA, tetB, tetC), colistin (mcr-1 to mcr-5), sulphonamides (sul1, sul2), quinolones (qnr A/B/S, aac(6’)-Ib-cr, qepA) resistance, and class 1 and 2 integrons were determined by PCR.
Results
ESBL-En [n = 45 (64.3%): 41 E. coli and 4 K. pneumoniae] isolates were collected. In E. coli, blaCTX-M-1, blaCTX-M-14, blaCTX-M-15, blaCTX-M-27, and blaCTX-M-55 genes were identified in 23, 2, 5, 16, and one isolate, respectively. The blaCTX-M-15 gene was detected in two K. pneumoniae isolates, while each of blaCTX-M-1 and blaCTX-M-27 were detected in one isolate. Resistances to tetracyclines, sulfonamides, fluoroquinolones, and colistin were encoded by tetA (n = 21)/tetB (n = 1), sul1 (n = 8)/sul2 (n = 13), aac(6’)-Ib-cr (n = 6), and mcr-1 (n = 2)/mcr-2 (n = 1) genes, respectively. Integrons of class 1 and class 2 were detected in 15 and six isolates, respectively. Five E. coli isolates belonged to the pandemic ST131 clone.
Conclusions
Our findings highlight the high occurrence of MDR/ESBL-En and demonstrate the possible transfer of these strains to humans via the food chain or direct contact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Tunis El Manar, Laboratory of bacteriological research, Tunisian Institute of Veterinary Research, Bab Saadoun, Tunis 1006, Tunisia.
- University of Manouba, Higher Institute of Biotechnology of Sidi Thabet, BVBGR-LR11ES31, Biotechnopole Sidi Thabet, Ariana 2020, Tunisia.
- University of Tunis El Manar, Faculty of Medicine of Tunis, Research Laboratory 'Antimicrobial Resistance' LR99ES09, Tunis 1006, Tunisia.
Zitieren
APA
Romdhani, A., Dhaouadi, S., Cheriet, S., Lengliz, S., Boutiba-Ben Boubaker, I., Landolsi, R. B., & Abbassi, M. S. (2025). Genetic characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae collected from healthy turkeys. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18973
Vancouver
Romdhani A, Dhaouadi S, Cheriet S, Lengliz S, Boutiba-Ben Boubaker I, Landolsi RB, et al. Genetic characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae collected from healthy turkeys. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.18973
BibTeX
@article{Romdhani2025,
author = {Romdhani, Amel and Dhaouadi, Sana and Cheriet, Sarah and Lengliz, Sana and Boutiba-Ben Boubaker, Ilhem and Landolsi, Ramzi Boubaker and Abbassi, Mohamed Salah},
title = {Genetic characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae collected from healthy turkeys},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.18973}
}
EUVIMED